PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada leen.naji@medportal.ca.\', \'Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.\', \'Department of Medicine, McMaster University, Hamilton, Ontario, Canada.\', \'Medical Science Gradaute Program, McMaster University, Hamilton, Ontario, Canada.\', \'Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.\', \'Biostatistics Unit, Research Institute at St Joseph\'s Healthcare, Hamilton, Ontario, Canada.\', \'Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2020-045946
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34493506
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all